Cargando…
RAB5A and TRAPPC6B are novel targets for Shiga toxin 2a inactivation in kidney epithelial cells
The cardinal virulence factor of human-pathogenic enterohaemorrhagic Escherichia coli (EHEC) is Shiga toxin (Stx), which causes severe extraintestinal complications including kidney failure by damaging renal endothelial cells. In EHEC pathogenesis, the disturbance of the kidney epithelium by Stx bec...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7080763/ https://www.ncbi.nlm.nih.gov/pubmed/32188865 http://dx.doi.org/10.1038/s41598-020-59694-w |
_version_ | 1783508058396164096 |
---|---|
author | Kouzel, Ivan U. Kehl, Alexander Berger, Petya Liashkovich, Ivan Steil, Daniel Makalowski, Wojciech Suzuki, Yutaka Pohlentz, Gottfried Karch, Helge Mellmann, Alexander Müthing, Johannes |
author_facet | Kouzel, Ivan U. Kehl, Alexander Berger, Petya Liashkovich, Ivan Steil, Daniel Makalowski, Wojciech Suzuki, Yutaka Pohlentz, Gottfried Karch, Helge Mellmann, Alexander Müthing, Johannes |
author_sort | Kouzel, Ivan U. |
collection | PubMed |
description | The cardinal virulence factor of human-pathogenic enterohaemorrhagic Escherichia coli (EHEC) is Shiga toxin (Stx), which causes severe extraintestinal complications including kidney failure by damaging renal endothelial cells. In EHEC pathogenesis, the disturbance of the kidney epithelium by Stx becomes increasingly recognised, but how this exactly occurs is unknown. To explore this molecularly, we investigated the Stx receptor content and transcriptomic profile of two human renal epithelial cell lines: highly Stx-sensitive ACHN cells and largely Stx-insensitive Caki-2 cells. Though both lines exhibited the Stx receptor globotriaosylceramide, RNAseq revealed strikingly different transcriptomic responses to an Stx challenge. Using RNAi to silence factors involved in ACHN cells’ Stx response, the greatest protection occurred when silencing RAB5A and TRAPPC6B, two host factors that we newly link to Stx trafficking. Silencing these factors alongside YKT6 fully prevented the cytotoxic Stx effect. Overall, our approach reveals novel subcellular targets for potential therapies against Stx-mediated kidney failure. |
format | Online Article Text |
id | pubmed-7080763 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-70807632020-03-23 RAB5A and TRAPPC6B are novel targets for Shiga toxin 2a inactivation in kidney epithelial cells Kouzel, Ivan U. Kehl, Alexander Berger, Petya Liashkovich, Ivan Steil, Daniel Makalowski, Wojciech Suzuki, Yutaka Pohlentz, Gottfried Karch, Helge Mellmann, Alexander Müthing, Johannes Sci Rep Article The cardinal virulence factor of human-pathogenic enterohaemorrhagic Escherichia coli (EHEC) is Shiga toxin (Stx), which causes severe extraintestinal complications including kidney failure by damaging renal endothelial cells. In EHEC pathogenesis, the disturbance of the kidney epithelium by Stx becomes increasingly recognised, but how this exactly occurs is unknown. To explore this molecularly, we investigated the Stx receptor content and transcriptomic profile of two human renal epithelial cell lines: highly Stx-sensitive ACHN cells and largely Stx-insensitive Caki-2 cells. Though both lines exhibited the Stx receptor globotriaosylceramide, RNAseq revealed strikingly different transcriptomic responses to an Stx challenge. Using RNAi to silence factors involved in ACHN cells’ Stx response, the greatest protection occurred when silencing RAB5A and TRAPPC6B, two host factors that we newly link to Stx trafficking. Silencing these factors alongside YKT6 fully prevented the cytotoxic Stx effect. Overall, our approach reveals novel subcellular targets for potential therapies against Stx-mediated kidney failure. Nature Publishing Group UK 2020-03-18 /pmc/articles/PMC7080763/ /pubmed/32188865 http://dx.doi.org/10.1038/s41598-020-59694-w Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Kouzel, Ivan U. Kehl, Alexander Berger, Petya Liashkovich, Ivan Steil, Daniel Makalowski, Wojciech Suzuki, Yutaka Pohlentz, Gottfried Karch, Helge Mellmann, Alexander Müthing, Johannes RAB5A and TRAPPC6B are novel targets for Shiga toxin 2a inactivation in kidney epithelial cells |
title | RAB5A and TRAPPC6B are novel targets for Shiga toxin 2a inactivation in kidney epithelial cells |
title_full | RAB5A and TRAPPC6B are novel targets for Shiga toxin 2a inactivation in kidney epithelial cells |
title_fullStr | RAB5A and TRAPPC6B are novel targets for Shiga toxin 2a inactivation in kidney epithelial cells |
title_full_unstemmed | RAB5A and TRAPPC6B are novel targets for Shiga toxin 2a inactivation in kidney epithelial cells |
title_short | RAB5A and TRAPPC6B are novel targets for Shiga toxin 2a inactivation in kidney epithelial cells |
title_sort | rab5a and trappc6b are novel targets for shiga toxin 2a inactivation in kidney epithelial cells |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7080763/ https://www.ncbi.nlm.nih.gov/pubmed/32188865 http://dx.doi.org/10.1038/s41598-020-59694-w |
work_keys_str_mv | AT kouzelivanu rab5aandtrappc6barenoveltargetsforshigatoxin2ainactivationinkidneyepithelialcells AT kehlalexander rab5aandtrappc6barenoveltargetsforshigatoxin2ainactivationinkidneyepithelialcells AT bergerpetya rab5aandtrappc6barenoveltargetsforshigatoxin2ainactivationinkidneyepithelialcells AT liashkovichivan rab5aandtrappc6barenoveltargetsforshigatoxin2ainactivationinkidneyepithelialcells AT steildaniel rab5aandtrappc6barenoveltargetsforshigatoxin2ainactivationinkidneyepithelialcells AT makalowskiwojciech rab5aandtrappc6barenoveltargetsforshigatoxin2ainactivationinkidneyepithelialcells AT suzukiyutaka rab5aandtrappc6barenoveltargetsforshigatoxin2ainactivationinkidneyepithelialcells AT pohlentzgottfried rab5aandtrappc6barenoveltargetsforshigatoxin2ainactivationinkidneyepithelialcells AT karchhelge rab5aandtrappc6barenoveltargetsforshigatoxin2ainactivationinkidneyepithelialcells AT mellmannalexander rab5aandtrappc6barenoveltargetsforshigatoxin2ainactivationinkidneyepithelialcells AT muthingjohannes rab5aandtrappc6barenoveltargetsforshigatoxin2ainactivationinkidneyepithelialcells |